Ignite Creation Date:
2025-12-26 @ 11:09 AM
Ignite Modification Date:
2025-12-29 @ 8:00 AM
Study NCT ID:
NCT00396812
Status:
TERMINATED
Last Update Posted:
2013-02-12
First Post:
2006-11-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rituximab for the Treatment of Early Rheumatoid Arthritis (RA)
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
DAIT ARA04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |